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in Embryonic  Mouse  Cells* 
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Kenneth P. ChepenikSO, Arturo Diad, and  Sergio A, Jimenea 
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Thomas  Jefferson  university,  Philadelphia,  Pennsylvania 19107 
Confluent,  primary cultures of mouse  embryo  palate 
mesenchyme (MEPM) cells are  refractory to activation 
of phospholipase A, ( P w )  by the calcium ionophore 
A23187.  However, treatment  of these cultures with epi- 
dermal  growth  factor  (EGF)  permits the cells to activate 
P w  in response  toA23187. We have  developed this find- 
ing by exploring  molecular  mechanisms by which 
growth  factors  modulate  mobilization  and  metabolism 
of arachidonic  acid. We found  chronic  treatment (>6 h) 
of  confluent MEPM cells with EGF (a) increases their 
ability to metabolize exogenous arachidonic acid to 
prostaglandin E, (PGE,)  and ( b )  stimulated constitutive 
expression of activities of P w  and cyclooxygenase 
(CyOx).  Immunoprecipitation  of  [s6S]proteins  and West- 
ern blot analysis revealed EGF treatment stimulated 
synthesis and  accumulation  of P-, CyOx-1,  and 
CyOx-2.  Northern  hybridization analysis revealed EGF 
increased the steady-state levels of  a  transcript  for the 
high molecular  weight, cytosolic P w  ( P w J ,  and  both 
the 2.8-  and  4.2-kb  transcripts  for CyOx-1 and CyOx-2, 
respectively. In vitro nuclear  transcription assays 
showed  a  parallel  increase in the transcription  rate  of 
the genes corresponding to CyOx-1 and P w , ,  but  not 
CyOx-2, in response to EGF. Treatment  with EGF had no 
effect  on either synthesis of the low  molecular  weight, 
group I1 P w ,  accumulation of its transcript, or the 
transcription  rate of its gene. Coordinate  regulation of 
activities of P w  and CyOx in response to EGF did  not 
parallel the mitogenic effects of EGF on confluent 
MEPM cells. 
The  cellular  synthesis of PGs’ involves  mobilization and me- 
tabolism of precursor  fatty acids (primarily  arachidonic  acid) 
from intracellular  stores (reviewed in Ref. 1). The  primary  en- 
zyme involved in mobilization of arachidonic acid appears  to be 
a P-, though some arachidonic acid may be released from 
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The  abbreviations  used  are:  PGs,  prostaglandins; CyOx, cyclooxy- 
genase; DMEM, Dulbecco’s modified Eagle’s medium; EGF, epidermal 
growth  factor;  GAGS,  glycosaminoglycans;  HPLC,  high pressure  liquid 
chromatography; MEPM, mouse embryo palate mesenchyme; MOPS, 
trophoresis; P-, phospholipase&;  TGFB,,  transforming  growth  factor 
3-(N-morpholino)-propanesulfonic acid;  PAGE,  polyacrylamide  gel  elec- 
beta,; cpm, countdmin; kb, kilobase(s). 
phospholipids by sequential hydrolysis via phospholipase C 
and diglyceride lipase.  Unesterified  arachidonic acid is metabo- 
lized to  the  PG hydroperoxide PGGz and  then  to  the endoper- 
oxide PGH, by the  same enzyme complex termed  PG G/H syn- 
thase (E.C. 1.12.99.1; commonly referred to  as cyclooxygenase). 
Therefore, the key  enzymes involved in  regulating  synthesis of
PGs are P- and CyOx (reviewed in Refs. 1, 2). 
Mammalian cells appear  to  contain at least  three  classes of 
P-: Group I (P-J, low molecular mass (<30 kDa) enzymes 
which are found in digestive organs,  such as pancreas,  and  are 
structurally homologous with P- found in  Elapidae venom 
(3); Group II(PLA,& low molecular mass (<30 kDa)  enzymes 
which are widely distributed  throughout  the  tissues  and cells of 
the body and have a structure in common with that of Crotali- 
dae venom, where  the C y ~ ” - C y s ~ ~  disulfide bond of P-, is 
missing  and replaced by a C y ~ ~ ~ - C y s ’ ~ ~  disulfide bond (3); and 
the recently purified (4-6) high molecular mass (>60 m a ) ,  
cytosolic P L 4  (P-,) which may not be classified as either 
Group  I or 11. The  extent  to which the P&,, and P-, regu- 
late mobilization of arachidonic acid destined for  metabolism to 
PGs  is  not clear. P-, may be secreted from cells and  has  been 
implicated as playing a critical  role in inflammation (reviewed 
in Ref. 7). P-, is not  secreted from cells and,  unlike P-,,, is 
highly specific for phospholipids  which contain  arachidonic acid 
in  the sn-2 position (5,8-ll), making  it a candidate  regulatory 
enzyme in synthesis of eicosanoids (4, 12). 
We found  recently that activities of PI.& may be stimulated 
readily by treatment of growing cultures of MEPM  cells with 
A23187 (13). In contrast, confluent cultures of MEPM cells 
were  quite  refractory  to  activation of P- by A23187 unless 
they  were  treated briefly with  EGF  or phorbol ester (13). These 
findings  prompted  the  hypothesis that regulation of mobiliza- 
tion  and metabolism of arachidonic acid might be part of the 
signaling  pathway by which EGF  modulated development of 
the  palate. We have explored this hypothesis by determining 
molecular mechanisms by which EGF (and TGFB,) might 
modulate mobilization and  metabolism of arachidonic acid by 
MEPM cells over an extended period of time. MEPM cells have 
receptors for both (14-16) of these growth factors,  which have 
have  been  shown  to  interact  in  regulation of metabolism of 
arachidonic acid in other  cellular  systems (17). 
MATERIALS AND METHODS 
Murine Palatal Cell Culture-Mature NJ strain mice (Jackson Labo- 
ratories, Bar  Harbor,  ME)  were  mated overnight,  and the presence of a 
vaginal  plug the following  morning (first day of gestation) was consid- 
ered evidence of mating. Embryos were obtained on the E t h  day of 
gestation  and  dissected  from uteri in sterile phosphate-buffered  saline. 
This  developmental  stage  was  chosen as  it is a time  when it is possible 
to obtain the maximum  number of embryonic palate mesenchyme  cells 
from palates still undergoing organogenesis. Palatal processes dis- 
sected  from the embryos  were  minced and  then  dissociated  to  produce a 
suspension of single cells that was seeded into 8-cm2 culture dishes 
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using  routine  laboratory  procedures (18-20) and grown  to confluence in  
DMEM (high glucose) that  contained 10% fetal bovine serum, 2 mM 
glutamine, 100 pg of streptomycidml,  100  units of penicillidml,  and 
0.25 pg of Fungizone/ml  (complete DMEM) (18). The  cells  were  then 
washed  with  serum-free  medium  and  incubated  24  h  in  defined  medium 
(19) which  consisted of DMEM/Ham's F-12 (5050, v/v), 1 mg of fetuid 
ml,  antibiotics  and  antimycotics as above, and ITS' (6.25  pg of insulin, 
6.25  pg of transferrin,  6.25  ng of selenous  acid,  5.35  pg of linoleic acid, 
and  1.25  mg of bovine serum  albumidml; Collaborative  Research, Lex- 
ingham, MA), prior  to  beginning  any  treatment  regimen.  At  the  end of 
24 h, the medium was removed, and the cells incubated in defined 
medium  alone,  or  defined  medium  which  contained  EGF  (Collaborative 
Research)  and/or  TGFp,  (Collaborative  Research) a t various  concentra- 
tions. All cell cultures  were  maintained at 37 "C in a  humidified  incu- 
bator  which  contained an  atmosphere of 5% CO,,  95% air. 
Determination of Cellular Proliferation-To measure  the effects of 
EGF  on  cellular  proliferation,  incorporation of [methyE-3HIthymidine 
(20 Citmmol; DuPont-NEN)  into  the  acid-insoluble  fraction of cellular 
extracts  was  determined.  Essentially,  confluent  cultures of MEPM cells 
were  incubated for either  24,48,  or  72 h in defined  medium  alone  or in 
medium  which  contained 20 ng of EGF/ml.  This  concentration of EGF 
was  found  to  be as effective as 10% fetal bovine serum  in  supporting 
growth of subconfluent  cultures of MEPM cells in defined  medium (19). 
Five  pCi of ['Hlthymidine  were  added  per  milliliter of culture  medium 
for the  last 3 h of each 24-h incubation period. The  medium  was  then 
removed and  the cells  precipitated  over ice for 1 h by addition of 1 ml of 
fresh, cold (4 "C) 10% trichloroacetic acid to  the  culture  dish.  The  cells, 
in 10% trichloroacetic acid, were scraped into Eppendorpf microfuge 
tubes,  stored  overnight at 4 ", and  then pelleted by centrifugation for 30 
s in a microfuge, sonicated  to  homogeneity  in  fresh, cold  10% trichloro- 
acetic  acid, and  washed  two  times  with  fresh 10% trichloroacetic  acid. 
The  washed  precipitates  were  neutralized  with 1 N NaOH  and  their 
radioactivities  determined  by  scintillation  spectrometry. 
AssayforActiuities ofCyOx and  PLA,-MEPM cells  cultured  in 8-cm2 
dishes  were  superfused 15 min  with 13 p~ [l-'4Clarachidonic acid (0.1 
pCi/ml; 40-60 mCi/mmol, DuPont-NEN)  in  defined  medium  plus  3  mg 
of defatted bovine serum  albumidml  in  order  to  measure  their  capacity 
to  metabolize  arachidonic acid (total  activity of CyOx). The  medium  was 
extracted  into  ethyl  acetate  according  to  Flower  et  al.  (21)  and  chro- 
matographed  with  authentic  PGs  and  arachidonic acid on thin  layer 
chromatography  plates  in  the  organic  phase of ethyl  acetate/isooctane/ 
acetic  acid/water (55:25:10:50, v/v). Radiolabeled  lipids  were  located by 
fluorography,  scraped  into  individual  scintillation  vials,  and  their ra- 
dioactivities determined by scintillation spectrometry. Correction for 
quench  was by the  external  standards  ratio  method.  In  some  cases  the 
nature of the radiolabeled  product  was  confirmed by HPLC. In  this case, 
medium which had  been  purified  and  concentrated  over a C,, column 
was injected,  in  ethanol,  onto an  Ultrasphere ODS C,, column  equipped 
with a precolumn. Radiolabeled arachidonic acid and its metabolites 
were  separated  in  a  solvent  gradient of 0.1% aqueous  acetic acid (Sol- 
vent A) and  acetonitrile  (Solvent  B)  programmed to increase  from  32% 
B to 90% B over a period of 102 min. Radioactivity in the column 
effluent  was  detected  on-line  (model  171  radioisotopic  detector, Beck- 
man  Instruments,  Fullerton, CAI. This  procedure  allows  separation of 
arachidonic acid and  30 of its metabolites  one  from  the  other  (22). 
In  order  to  determine  the  ability of MEPM  cells  to mobilize arachi- 
donic acid from endogenous pools and metabolize it  to  PGs, cells were 
grown  to confluence in complete DMEM and  then  incubated  24  h  in 
complete DMEM which contained 0.5 pCi/ml of [5,6,8,9,11,12,14,15- 
3Hlarachidonic acid (60-100 Citmmol; DuPont-NEN). This procedure 
results  in  incorporation of L3H1arachidonic acid into  the  sn-2  position of
all major  classes of phospholipids in MEPM  cells  (23).  The  medium  was 
then removed and the cells  washed  three  times  with  warm (37 "C), 
defined  medium  which  contained  3  mg of defatted bovine serum 
albumidml.  The cells were  then  incubated  overnight  in  defined  me- 
dium  prior  to  treatment  with  EGF  or TGFB,. At  the  end of the  treatment 
period the  medium  was collected, extracted  into  organic  solvent,  and 
subjected  to  thin  layer  chromatography as described above. The  cells 
were  then  stimulated  with  10 p~ A23187 in HEPES-buffered  saline (5 
mM CaCl,, 0.49 mM MgSO,, 0.373 m~ KC1, 0.137 m~ NaCl, 3 mg of 
defatted bovine serum  albumin,  20 mM HEPES,  pH 7.4). Cellular  lipids 
were  extracted  into  organic  solvent  according to  Bligh and Dyer  (24) 
except the  methanol  contained 2% acetic acid. Phospholipids  were  sepa- 
rated from each other by chromatography on Whatman KD6 plates 
(Fisher)  in CHC13/CH,0WCH3COOH/H,0, 50:25:8:2 (v/v), along with 
authentic  standards;  neutral  lipids  were  separated by chromatography 
on  Whatman KD5 plates  in CHC13/CH,0WCH,COOH, 98:2:1 (v/v). The 
chromatogram  was  visualized by staining  with I, vapors,  and  the  indi- 
vidual  lipids  were  each  scraped  into a scintillation  vial  and  their  radio- 
activities  determined as described above. 
Immunoprecipitation ofP5SIProteins--In order to  radiolabel  proteins 
synthesized  in  response to  various  treatments,  cells  were  incubated  in 
cystine/methionine-free  medium for the  last 15 min of the  treatment 
period, and  then  incubated  2  h  in  cystindmethionine-free  medium  to 
which 100 pCi of [35S]methionine/[35Slcystine (>lo00 Ci/mmol; Trans 
35S-Labeltm, ICN Biomedicals, Costa Mesa, CA) were addedml. The 
cells  were then  washed  and  lysed  in 1 ml of 50 m~ HEPES,  pH 7.5, 
which  contained 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM 
MgCl,, 1 mM EGTA, 1 mM phenylmethylsulfonyl  fluoride,  4  pg of leu- 
peptin,  and 10 pg of aprotinin.  Twenty  pl of lysate  were  precipitated 
with 10% trichloroacetic acid and  the  amount of radioactivity deter- 
mined by scintillation  spectrometry. An aliquot of lysate  equivalent  to 
lo6 cpm as trichloroacetic  acid-insoluble  material  was  then  immuno- 
precipitated essentially according to Margolis et al. (25). Briefly, the 
sample  was  incubated at 4 "C for 1 h  with  normal  rabbit  serum,  then 1
h with  Protein  A-Sepharose,  and  then  centrifuged 5 min  at 10,000 x g  to 
produce a clarified supernatant. The clarified supernatant was then 
incubated 90 min a t  4 "C with  either  rabbit  anti-sheep  seminal vesicle 
CyOx ((26) gift of Dr. William Smith, Biochemistry, Michigan State 
University, East Lansing, MI), rabbit anti-human P a ,  ( g i f t  of Dr. 
James  Clark,  Genetics  Institute,  Cambridge, MA), or  rabbit  anti-hu- 
man  recombinant  synovial  fluid P-, (gift of Dr. Lisa  Marshall,  Smith 
Kline,  Beecham,  King of Prussia, PA), and  then 1 h  with  Protein A- 
Sepharose  (Sigma).  This  procedure  was  repeated  sequentially  with  each 
of the  antibodies of interest so as  to  obtain  a  measure of the effects of 
EGF  and/or TGF,, on multiple  proteins  extracted from a single popu- 
lation of cells. The  Protein A-Sepharose-antibody-antigen complex was 
collected by centrifugation,  suspended  in a small  amount of SDS-PAGE 
sample buffer, and boiled 5 min  to  solubilize  proteins. CyOx and   PL4,  
were  resolved  by  electrophoresis on 12% gels, and P a , ,  was resolved 
by electrophoresis  on 20% gels.  The  gels  were  then  impregnated  with 
Autoflour (National Diagnostics, Atlanta, GA), dried under vacuum, 
and visualized by fluorography.  Controls  consisted of Protein  A-Sepha- 
rose-protein complexes obtained  with  normal  rabbit  serum  as well as 
samples  to  which  microgram  quantities of unlabeled,  authentic  antigen 
had been  added. 
Immunoblots (Western B1ots)"MEPM cells  treated  with  EGF and/or 
TGF,, were extracted into SDS-PAGE buffer, separated by electro- 
phoresis on 12% gels, and then blotted onto supported nitrocellulose 
(MSI, Westboro, MA) according to  Towbin et  al.  (27).  The  blots  were  then 
masked  with 0.1% Tween 20 and  incubated  with  appropriate  dilutions 
of specific antibodies. Rabbit anti-murine CyOx-2 antibody was ob- 
tained from Cayman  Chemical Co. (Ann Arbor, MI). Antigen-antibody 
complexes were  visualized  using  alkaline  phosphatase-linked ABC re- 
agents commercially available from Vector Laboratories (Vectastain 
ABC kit, Vector Laboratories,  Burlingame, CA). 
Northern Blot Analysis-Cells were grown to confluence in T-75 
flasks  and  treated  24  h  with or without  growth  factors.  They  were  then 
lysed in  4 M guanidinium  isothiocyanate, 5 mM sodium  citrate,  pH 7.0, 
0.5% Sarkosyl,  and 0.1 M P-mercaptoethanol. Total RNAwas  isolated by 
the discontinuous CsCl, gradient as described in Sambrook  et  al.  (28). 
Ten pg of total  RNNsample  was  denatured  in  formaldehyde  and  sub- 
jected  to  electrophoresis in 0.8% agarose, 6% formaldehyde gels in 20 
mM MOPS,  5 mM sodium  acetate, 1 mM EDTA, pH 7.0. Equal  loading of 
RNA was verified by visual inspection of ethidium bromide-stained 
ribosomal RNA. RNA was transferred in a vacuum blotting system 
(LKB 2016 Vacugene, Piscataway, NJ) to a supported nitrocellulose 
membrane  in 10 x SSC  (1.5 M NaC1,0.15 M sodium  citrate,  pH 7.0) and 
cross-linked to the membrane by U V  irradiation (W Stratalinker, 
Stratagene,  La  Jolla, CAI. Membranes  were  prehybridized  overnight a t  
42 "C in 50% formamide, 5 x concentrated  Denhardt's  solution (0.5 g of 
in 500 ml of  H,O), 5 x SSPE (1.8 M NaC1,O.l M NaHPO,, 0.01 M EDTA), 
Ficoll400,0.5  g of polyvinylpyrrolidone, 0.5 g of bovine serum albumin, 
0.1% SDS, and 200 pg of salmon  sperm  DNNml of solution.  The  mem- 
branes  were  then  hybridized  overnight  in  the  same  solution  to  which 
was  added  the  appropriate  cDNAradiolabeled  with [CY-~~PI~CTP by nick 
translation  (29)  to specific activities  higher  than 10, cpndpg DNA. The 
cDNAs employed were: an  800-base  pair EcoRL'PstI cDNA fragment of 
ra t  type I1 P- (PL4,; gift of J .  Ishizaki, Shionogi & Co., Ltd.,  Osaka, 
Japan; (30)),  a  1.8-kb EcoRI cDNAfragment of mouse CyOx I (gift of Dr. 
David  DeWitt, Biochemistry, Michigan State University, East  Lansing, 
MI; (31)), a 4.2-kb EcoRI cDNA for mouse CyOx-2 (gift of Dr. Dean 
Kujubu  (32)), a 2.4-kb EcoRI cDNA fragment of mouse P-, (gift of Dr. 
James  Clark,  Genetics  Institute,  Cambridge, MA (4)),  and a 600-base 
pair EcoRL'BamHI  cDNA fragment of human  actin,  After  hybridizations 
the blots  were  washed at 55 "C in  decreasing  concentrations of SSC, 
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with a final  wash  in  0.25 x SSC, 0.1% SDS.  Autoradiographs  prepared 
by exposing the blots  to X-omat-AR film  were  quantified by scanning 
laser  densitometry. 
In  Vitro Nuclear Danscription Assay-The transcription rates of 
P q  and CyOx genes  were  determined by the  in vitro nuclear run-off 
assay (33). For  this purpose,  MEPM  cells  obtained as described above 
were  cultured  in T-175 flasks  and  incubated  in  the  presence  or  absence 
of EGF  (20  ng/ml) for 24 h.  At  the  end of the  incubation period, cell 
layers  were  trypsinized,  nuclei  prepared  as  described  previously (341, 
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FIG. l. Effects of EGF and TGF l on metabolism of exogenous 
tures of MEPM  cells  were  incubated  72 h with  growth  factors, as indi- 
cated, or with  medium  alone  (None) and  then  superfused  with  13  p~ 
[l4C1arachidonic acid  for 15 min.  The  medium  was  extracted  and  ana- 
lyzed for radiolabeled  PGs by thin  layer  chromatography  and  scintilla- 
tion  spectrometry. *, p < 0.05 when  compared  with  controls  (None); **, 
p < 0.005 when  compared  with  controls,  TGFP,  alone,  or  EGF  alone, as 
determined by t test (35). Each  data  point  represents  the  mean (tS.E.) 
of three  separate  experiments. 
and  stored at -70  "C until  used.  The  transcription  reactions  were  car- 
ried  out in a volume of 200 pl of 10 mM Tris, pH 8.0,90 mM KC&, 3 mM 
MgCl,, 2 mM dithiothreitol, 1 unit of RNasin Ribonuclease Inhibitor 
(Promega,  Madison, WI)/ml, 0.4 mM each ofATP, UTP, and GTP, and 0.5 
mCi [c~-~'PICTP  (DuPont-NEN,  800 Cilmmol). Incubations  were for 25 
min at  25 "C, and incorporation of [C~-~~P]CTP was followed by trichlo- 
roacetic acid precipitation of l-pl aliquots. Transcription was termi- 
nated by the  addition of 900 pl of a buffer  containing  100 mM NaCl,  10 
mM Tris-HC1, pH 7.5, 2 m~ KCl,, 1 mM EDTA, and 0.5% SDS. To each 
sample  100  pg of yeast  tRNA  and  100  pg of proteinase  K  were  added  per 
ml,  digested  for 60 min a t  42 "C, extracted  with  phenolkhloroform, and 
precipitated  in 10% trichloroacetic  acid and 10% (v/v) saturated sodium 
pyrophosphate.  The  pellets  were  washed  with 70% ethanol,  dried,  and 
dissolved in 100 1.11 of 10 mM Tris-HC1, pH 7.4, 1 mM EDTA, and 0.1% 
SDS. An additional  100  pg of yeast  tRNA  was  added,  the  solution  made 
2.5 M in  ammonium  acetate,  and  the  nucleic  acids  precipitated by ad- 
dition of 100% ethanol.  The  pellets  were  dissolved in 100  pl of a buffer 
containing  20 mM Tris-HC1, 10 mM MgCl,, and  2 mM CaCl,, pH 7.5, and 
incubated for 30  min a t  37 "C with  100 pg of RNase-free  DNase/ml  and 
1 unit  RNasidpl.  Samples  were  extracted  with phenoVchloroform and 
precipitated  with  ethanol  in  0.3 M sodium  acetate.  Labeled  transcripts 
were resuspended in prehybridization buffer, and duplicate 5-pl ali- 
quots were precipitated in 10% trichloroacetic acid. The precipitates 
were  trapped  on  filter  paper  and  their  radioactivities  determined by 
scintillation  spectrometry.  17 x lo6 cpm from each  sample  were  adjusted 
to 500 pl  in  the  same  buffer  and  were  hybridized to  filters  containing 
linearized,  denatured,  and immobilized Bluescript  plasmid  or  plasmids 
containing cDNAs for murine CyOx-1, murine CyOx-2, rat P q , ,  or 
murine P-,. The  dots  were  previously  cut  out  and  prehybridized  in 
50% formamide, 5 x Denhardt's  solution,  4 x SSC, 0.1% SDS,  0.1 mg of 
salmon  sperm DNA/ml for 4 h.  Hybridizations  were  carried  with con- 
tinuous  shaking at 42 "C for 48  h.  After  hybridization, the filters  were 
washed  for 15 min  in  2 x SSC at room temperature,  then  for 15 min  in 
0.2 x SSC at 55 "C, and  treated  with  RNase  A (10 pg/ml in 2 x SSC) for 
5 min a t  37 "C. The  filters  were  then  washed  in  2 x SSC, 0.1% SDS for 
15  min at room temperature  and  dried.  Autoradiographs  were  obtained 
and  scanned  in a laser  densitometer.  The  amount of 32P hybridized  to 
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h 
ng  EGF/ml  medium  and  superfused  with  13 PM [14C]arachidonic as  in Fig. 1.  Purified and  concentrated medium  was injected  onto an  Ultrasphere 
FIG. 2. High  pressure  liquid  chromatographic  separation  of  metabolites f [14C]arachidonic acid. MEPM cells were  incubated  with  20 
ODS  column,  with  precolumn.  Arachidonic acid and  its  metabolites  were  separated  in a solvent  gradient of 0.1% aqueous  acetic acid (Solvent A) 
and  acetonitrile  (Solvent B) programmed  to  increase from 32% B to 90% B over a period of 102  min.  Radioactivity in  the column  effluent  was 
detected  online.  137,000  disintegrationdmin as 14C were  injected  onto the column.  Untreated  cells did not  synthesize  sufficient [l4C1PGs to detect 
by HPLC (data not  shown). PGE,, prostaglandin E,; A A ,  arachidonic  acid. 
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arachidonic  acid by  MEPM cells treated for various lengths of 
FIG. 3. Effects of EGF and TGFP, on  metabolism of exogenous 
time. Confluent, primary cultures of  MEPM cells  were incubated 6-72 
h in defined  medium  alone (0) or with EGF and TGF,, (0). At various 
intervals  the cells  were superfused with ['4Clarachidonic  acid and the 
medium analyzed for  production of [l4C1PGEZ, as described in Fig. 1. 
Each data point represents  a  separate xperiment. Analysis of variance 
revealed significant ( p  < 0.001) interaction between time and growth 
factor treatment  in stimulating release of ['4C]PGE,. 
each blot was determined by scintillation counting. 
Laser Densitometry-Autoradiographs and blots were scanned with a 
Molecular  Dynamics Personal Densitometer (Molecular  Dynamics, 
Sunnydale, CA).  Volume integrations with subtraction of appropriate 
backgrounds were performed with soRware provided by Molecular 
Dynamics. 
Statistical Analysis-Analysis of variance was performed using soft- 
ware from Human Systems Dynamics (Northbridge, CA). Data were 
analyzed also using a modified t test according to formulas outlined by 
Wallenstein et al. (35). 
RESULTS 
Treatment of confluent cultures of  MEPM cells  for 72 h with 
as much as 10 ng TGF,,/ml had no  effect  on the ability of these 
cells to metabolize exogenous arachidonic acid to PGs (Fig. 1). 
However, treatment with EGF promoted metabolism of  exoge- 
nous arachidonic acid to PGE, in a dose-dependent fashion 
(Fig. 1). Though TGF,,  by itself had no effect, it potentiated the 
ability of EGF to increase metabolism of exogenous arachidonic 
acid to  PGE, (Fig. 1). PGE, was the predominant PG synthe- 
sized, as determined by thin layer chromatography and HPLC 
(Fig. 2). 
The growth factors stimulated metabolism of exogenous 
arachidonic acid to PGE, in  a  linear fashion for at least 72 h 
(Fig. 3). In  contrast, EGF stimulated cellular synthesis of  DNA 
only in  the first 24 h of treatment;  thereafter  synthesis of  DNA 
returned to that typical of the nonproliferative state (Fig. 4). 
Initiation of a single round of DNA synthesis in response to 
addition of a growth factor to confluent, quiescent cultures of 
these embryonic  cells is a response typical of cultures of non- 
transformed cells (36). 
Once it was determined that  the growth factors could indeed 
alter  the capability of MEPM cells to metabolize exogenous 
arachidonic acid, cells prelabeled with [3H]arachidonic acid 
were used to determine whether the growth factors similarly 
altered the ability of the cells to mobilize and/or metabolize 
endogenous stores of arachidonic acid. In  this case, confluent 
MEPM cells prelabeled with [3H]arachidonic acid and  treated 
with EGF released relatively more free [3H]fatty acid and 
r3H1PGE, from  endogenous stores than did controls (Fig. 5 A ) .  
Forty-eight * 0.4% of the  total 3H released as free fatty acid and 
PGE,  from cells treated with EGF was found as PGE,, whereas 
only 15 f 0.5% of the total 3H released as free fatty acid and 
PGE,  from control cells was found as PGE, (Fig. 5 A ) .  TGF,, did 
not appear to potentiate significantly the effects of EGF on 
release of [3H]arachidonic acid  from  endogenous stores or  con- 
12000 I I I 
T 
2000 4 0 L"---- 24 40 72 
Length of Incubation (hours) 
FIG. 4. Effects of EGF on synthesis of DNA by MEPM cells. 
Confluent MEPM cells  were incubated 24 h in defined  medium, and 
then for  24,  48,  or 72 h in defined  medium  which contained 20 ng of 
EGF/ml (O), or in defined  medium  alone (0). Five  pCi of ['HIthymidine/ 
ml of medium was added to each culture for the  last 3 h of each  24-h 
period.  Radiolabeled  cells  were  collected in cold (4 "C) 10% trichloroace- 
tic acid, precipitated overnight at 4 "C, and the radioactivity in the 
precipitates determined as described under "Materials and Methods." 
Each data point represents the mean (e S.E.) of three  separate deter- 
minations. Values of p for comparisons of treated to  controls at each 
time point were obtained by t  test (35). 
version of endogenous [3H]arachidonic to L3H1PGE, (Fig. 5 A ) .  
Confluent cultures prelabeled with [3Hlarachidonic acid and 
then  treated with EGF mobilized  twice as much endogenous 
PHIfree fatty acid and L3H1PGE, in response to the calcium 
ionophore A23187 than did controls (Fig. 5B).  Thirty % of the 
radiolabel mobilized  by EGF-treated, ionophore-stimulated 
cells was converted to l3H1PGE,, whereas ionophore-stimulated 
controls (no EGF treatment) converted  only  10% of the mobi- 
lized radiolabel to  [3H]PGE, (Fig. 5B). Again, TGF,, did not 
appear  to  potentiate the effects of EGF on mobilization and 
metabolism of endogenous stores of L3H1fatty acid (Fig. 5B). 
Consistent with previous findings (13), L3H]fatty acid  was re- 
leased from all major classes of intracellular phospholipids in 
response to treatment with EGF and ionophore (Fig. 5C). No 
radiolabel was released from triglycerides since the amount of 
label found in  the triglyceride fraction of EGF-treated cells (4.1 
* 0.3%, n = 3) was not significantly different from that found in 
controls (5.4  0.6%, n = 3) subsequent to stimulation with the 
ionophore. 
Increased mobilization and metabolism of arachidonic acid in 
response to EGF was accompanied by increased synthesis of 
CyOx and PL4,  protein (Fig. 6). Scans of the autoradiographs 
presented in Fig. 6 revealed a 5-6-fold increase in CyOx and 
2.5-3-fold increase in PI& within 24 h of treatment. In- 
creased synthesis of these proteins continued for at least 72 h 
(Fig. 61, at which time synthesis of CyOx was as much as 33 
times that of controls and synthesis of  P&, was as much as six 
times that of controls. TGF,, itself did not have a noticeable 
effect (less than 2-fold increase relative to controls) on synthe- 
sis of CyOx or P&, after 24 or 72 h of treatment (Fig. 6). 
However, a potentiating affect of  TGF,,  on EGF-induced syn- 
thesis of  CyOx was readily detected after 72 h of treatment of 
cells with both growth factors (Fig. 6; 20 ng EGF/ml induced a 
15-fold increase in CyOx whereas 20 ng of EGF and 1 ng of 
TGF,,/ml induced a 33-fold increase in CyOx). There was no 
detectable effect of the growth factors on synthesis of proteins 
immunoprecipitated with antibody to P&,, (data not  shown). 
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FIG. 5. Effects of growth factors on mohilization and metaho- 
lism of endogenous arachidonic acid by MEPM cells. Confluent. 
primary  culturrs of MEPM crlls were rat1iol:thc~lcd with  I"1llarachidonic 
acid,  washrtl,  antl  thrn  incuhated 48 h  with  thc intlicatctl growth fac- 
tors.  The  mrdium  was  thrn collected and  rxtractrd.  Thr  crlls were th rn  
washed  and  stimulated 5 min  with 10 p~ A23187 in  HEPES-buffered 
salinr  containing 5 mh! CaCI,. Cells and  HEPES-huffrrrtl  saline  were 
collected  together  and  rxtracted.  The  various  extracts  were  analyzed  for 
radinlnheled  fatty  acids, PGs, and  phospholipids hy thin lnyrr chroma- 
tography. A, release of radiolaheled fatty acid (IMDSU3HIFFA) and 
P(;E, il"HlPGE,) into  the  medium  during  the  initial  48-h  incubation 
A23187; C, drplrtion of radiolaheled fatty acid from cellular phospho- 
prriod. B, radiolnhrlrd fatty acid and PGE, released in response to 
lipids. None: no addition of growth factors; PC, I ' S / P I ,  and ['E, 1.2- 
radyl-sn-glyccro-~-phosphocholine, -serine/-inositol  fraction,  -ethanola- 
mine.  Each hnr represrnts  the  mean (t S.E.) of three  separate 
experiments. Values of p .  indicated hy *, on comparing  the  response of 
EGF-treated cells to thrir  appropriate  controls  wcrr  determined hy I 
test (35). 
Increased  synthesis of PLA,, and CyOx was accompanied hy 
accumulation of PLA,,, CyOx-1, and  CyOx-2  proteins  (Fig. 7 A  ). 
The  anti-sheep  seminal  vesicle CyOx antihody  would  immuno- 
precipitate  both  isoforms of CyOx a s  i t  cross-reacts  with 
CyOx-2 (Fig. 7B ); the  anti-CyOx-2  antibody  did  not  detectably 
cross-react with sheep seminal vesicle cyclooxygenase (Fig. 
7B ). 
CyOx (70kD) 
P h c  
c y o x - 1  
C y O x - 2  
Laser scanning quantitation of autoradiokTaphs p r r p n r r d  
from  Northern  blots  revealed a 4-fold incrrnsr in stc:ldy-state 
levels of the  2.8- and  4.2-kh  transcripts for (&Ox-1 and CyOx-2. 
respectively,  and a 2.5-fold incrrnsr in stradv-state Irvcls of a 
3.0-kh mRNA for P U 2 ,  within  24  h of trratment  with EGF (Fit. 
8). In  contrast,  there  was  no  apparent  rffwt (Irss thnn 1 .fi timrs 
control  values) of any of thr growth factor trrntmrnts on 
steady-state  levels of the  2.2-kb  mRNA  for  thc low molrculnr 
weight,  Group I1 P U 2  (PIA2, , , ;  Fig. X). Thr  str:tdv-st.:ltc. 1c.vc.l of 
mRNA  for PLA,, in TGF,,,-trented  crlls  was 73 2 I T ;  11 = 3 )  of 
controls. 
In vitro nuclear run-off assays  rrvcalrd  thr incre:wrtl strady- 
state mRNA levels for CyOx-1 and PIA,,,. in r r s p o n s r  to K(;F 
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FIG. 8. Effects of EGF and TGF,, on steady-state levels of 
mRNA for CyOx, I'm,,,, P-, and actin in MEPM cells. Conflu- 
rnt .   primary  culturcs of' MEI'M crlls  wcrr  culturcd 21 h  with  drfinrd 
mrtlium  alonr ( C m t  t or with  lnedium  which  cont:linrd  eithrr 1 ng of 
TGF ( TGF',,), 20  ng of EGF (EGF ), or 1 ng of TGF,,, and  20  ng of EGF 
( B ( ; h / T G F , )  prr ml. Total  RNA was rxtrnctrd ns tlrscrihrcl under  "Ma- 
t r r inls   and  kr thods."  Trn pg of RNNsamplr   wrre  rlcctrophoresrtl on a 
0.8% agarosr grl. hlottrd onto nitrocrllulosr filtrrs, and hyhridized to 
:'T-lahrlrtl  cDNAs for CyOx-1, CyOx-2, PIA,,, or actin.  Autora- 
diographs prrpared from the  filters wrrr  scanned  with a laser tlrnsi- 
tomctrr. The size of thr  mRNAs detrctrd hy the various c1)NAs is 
indicated on thr Irp side of the  autoradiographs.   Northern blots arr 
rpprrsentntivr of th r re  separate rxprrimcnts. 
were at least  partially  the  result of an  increased  transcription 
rate  (Fig. 9 )  of the  genes for CyOx-1  and PL&. The  transcrip- 
tion  rate of the  genes for PLA,, (group I1 PLA.,) and  CyOx-2 
were  not  enhanced by treatment of MEPM  cells  with  EGF  (Fig. 
9). 
DISCUSSION 
Chronic treatment of MEPM cells with EGF clearly en- 
hanced  their  capacity  to  metabolize  arachidonic  acid  to PGE,. 
In  parallel,  EGF  induced  accumulation of the  mRNA  and  pro- 
tein for both CyOx-1 and CyOx-2. In contrast, induction of 
cyclooxygenase by treatment of some  other  types of cells  with 
mitogens  was  not  accompanied by induction of the  mRNA  for 
CyOx-1,  but  was  accompanied by induction of the  mRNA  for 
CyOx-2 (37-39).  EGF-induced  accumulation of CyOx-1  mRNA 
in  these  embryonic  cells  reflects  to  some  extent  enhanced  gene 
transcription,  whereas  accumulation of CyOx-2 mRNA  reflects 
primarily  regulation of message  stability.  Evett et nl. (40)  re- 
ported  dexamrthasone  inhibition of mitogen-induced  accumu- 
lation of CyOx-2 mRNA in NIH.7T.3 cells  was a t  the level of 
regulation of message stability since dexamethasone did not 
alter  the  rate of gene  transcription.  These  various  findings  lead 
to  the  conclusion  that  there is both cell and  agonist  specificity 
a s  to  which  isoform(s1 of CyOx i d a r e )  induced  and  the molec- 
ular  mechanism by which that  induction  takes  place. 
Although  TGF,,,  stimulates  synthesis of PGs by various  types 
of cells (; .e.  human  lung  fibroblasts  (41)  and  microvessel  endo- 
thelial  cells  (42)), i t  had  no  detectahle  effect  on  synthesis of PGs 
by MEPM cells. However, TGF,,, potentiated the stimulatory 
effects of EGF.  This is similar  to  the  situation  found  with  vas- 
cular  smooth  muscle  cells  (17).  wherein TGF,,, alone is a mod- 
erate  inducer of activity of CyOx but  significantly  potentiates 
the  inducing  effects of EGF. These  findings  most  likely  reflect 
TGF,4, modulation (up-regulation) of receptor levels for EGF 
(4.7). Such  receptor  up-regulation  would  result  in  an  enhanced 
response  to EGF. It  should  be  noted  that  interaction of growth 
factors in modulating receptor levels is quite complex since 
treatment of MEPM  cells  with TGF,,, in  the  presence of serum 
factors  down-regulates  receptors for EGF  (44). 
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The finding that TGF,,, potrntiatrd thr rffrcts of EGF on 
metabolism of exogenous  arachidonic  acid  without  potrntiating 
metabolism of endogenous  arachidonic  acid  may  nt  first  scrm 
paradoxical. However, it  may  br  that  only  thosr  molrculrs of 
arachidonic  acid mobilized  from rndogrnous  storrs  in  juxtnpo- 
sition  to  molecules of CyOx arr  mrtaholizrd  to  ricosanoids  and 
that  not all molecules of CyOx arr in  juxtaposition  to  intracrl- 
M a r  sites of mobilization of arachidonic  acid.  Exogrnous 
arachidonic  acid would hr  mrtaholizrd hy any  availablr mole- 
cule of CyOx,  whereas  endogenous  arachidonic  acid would he 
metabolized by only those molrculrs of CyOx couplrd to thr 
intracellular site of acyl mohilization.  In  such  a  casr  it would be 
possible  to  ohserve  a level of mrtaholism of rxogrnous  arachi- 
donic  acid that  may  not  he  matchrd hy Irvels of mrtabolism of 
endogenous  arachidonic  acid.  Indrrd,  although  thr  amount of 
arachidonic  acid  released from rndogcnous  storrs  was  in- 
creased by EGF, less  than  half  was  mrtnholizrd  to PGE,. Smith 
~t nl. (1) have  suggested  tight  coupling exists hrtwcrn  thr  en- 
dogenous pool of arachidonic  acid  which is mohilizrd  and  drs- 
tined for conversion  to  PGs  and  thr pool of CyOx through which 
it  is  metabolized. 
EGF induced constitutive exprrssion of activitirs of PLY, 
and CyOx in MEPM cells, as mcasurrd hy mobilization and 
metabolism of endogenous  arachidonic  acid.  This  rffcct of EGF 
on activity of thesr enz-ymes did not simply rrflrct thr mito- 
genic  properties of EGF  in  that   thry  did  not  parallr l   thr  rffrcts 
of EGF on synthesis of DNA. Furthermorr,  Constitutive  rxprrs- 
sion of activities of PLA.,! was  coordinatrd  with  incrrnscd 
steady-state  mRNA  lrvels for the  high  molrcular  wright. cyto- 
solic PLA,,, but not PLIL,, (a  PLA,,,). Srvrral invwtigntors 
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FIG. 10. A model depicting EGF regulation of gene  expression 
of enzymes  requisite  to  the  synthesis of lipid  signaling  mol- 
ecules as a mechanism for regulating  mesenchymal-mesenchy- 
mal  and  mesenchymal-epithelial  interactions  during  develop- 
ment of the  palate. In  this model,  EGF induces palate mesenchymal 
cells to  synthesize prostaglandins by inducing expression of PI.& and 
CyOx. These prostaglandins may then serve as molecular signals by 
which the mesenchyme  specifies terminal differentiation of the palate 
(reviewed in Ref. 481, and by which mesenchymal cells signal each other 
to  synthesize GAGS (49). This model is consistent with the evidence that 
EGF plays  some sort of role in modulating differentiation of the palate 
(reviewed in Ref. 50), that agents which inhibit synthesis of prosta- 
glandins will inhibit terminal differentiation of the palatal epithelium 
in vivo and in  vitro (51, 52) and that synthesis of GAGs in palatal 
mesenchyme is important in reorientation of the secondary palatal 
shelves from the vertical to  the horizontal position during embryogen- 
esis (53). 
reported very recently that either EGF (45) or interleukin (46) 
will increase mRNAlevels and protein synthesis of PW,  m rat 
mesangial cells, and Hoeck et al. (47) found a similar affect of 
TNF, on HeLa  cells.  However, to the best of our knowledge the 
findings herein are  the first to document  EGF-induced  coordi- 
nate expression of the genes for P W ,  and CyOx at  the level of 
transcription, accumulation of  mRNA, and  synthesis of protein. 
Such coordinate regulation of P W ,  and CyOx makes it likely 
the high molecular weight, cytosolic P& is regulatory for 
mobilization of arachidonic acid destined for metabolism to 
prostaglandins in this embryonic cell system. Furthermore, 
such chronic (long term) regulation of gene expression of P h C  
and CyOx provides a mechanism by which EGF may induce a 
signaling pathway thought to  be involved in regulating devel- 
opment of the palate (Fig. 10). These findings support the hy- 
pothesis that induction of synthesis of lipid signaling molecules 
is a major mechanism by which EGF regulates development of 
the  palate (Fig. 10). 
?D 
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